get a key
steadybase-$ person Roger Susie
nameRoger Susie
roleCEO
company iRadimed Corporation IRMD
linkedin none on file
contactnot published
filingsnone on file
quotes
Our continued revenue growth combined with discipline expense management including a modified commission structure drove operating income of $7.2 million, a 33% improvement over the first quarter of 2025.

Aug 7, 2026 / CEO / receipt / Roger Susie, CEO | earnings call 2026-08-07 | transcript 9395b62a-d40d-45b2-8205-c1ed4f69bcb7 | chars 2426-2630 | segment 2

steadybase-$